a new four-drug combination chemotherapeutic regimen ( bvds ) was used in the treatment of advanced hodgkin disease resistant to mopp ( mechlorethamine hydrochloride , vincristine sulfate , procarbazine hydrochloride , and prednisone ) .
C0019829
hodgkin disease
C0042680
vincristine sulfate